Indian Pharmaceutical Market Is One Of The Fastest Growing In The World

Indian Pharmaceutical Market Outlook 2009-2024

The rising Indian pharma market will achieve sales of close to $8 billion in 2009 and has enjoyed double-digit growth in the past five years, peaking at 25% in 2007. Will the Indian market continue to achieve high sales growth next decade? Our new report - Indian Pharmaceutical Market Outlook 2009-2024 explains, providing the information that you need to understand this crucial pharma opportunity. India is of rising importance as growth slows in the current leading markets. ( http://www.bharatbook.com/detail.asp?id=129531&rt=Indian-Pharmaceutical-Market-Outlook-2009-20241.html )

The strong growth registered by the Indian economy has helped to drive its pharmaceutical market and industry. That sector's growth in recent years has also been driven by India's expanding middle class, with growing affordability and greater access to healthcare. India currently accounts for over 5% of the Africa/Asia/Australasia market and is ranked 14th in the world pharmaceutical markets. The highly-competitive market in India continues to be dominated by Indian pharmaceutical companies, but remains fragmented, with over 20,000 licensed organisations. Besides many SMEs, competitors include internationally-recognised companies such as Cipla, Dr. Reddy's and Ranbaxy, as well as foreign multinationals.

India's pharmaceutical industry has strong potential for growth and will continue to be an attractive sector for both domestic and foreign companies, Indian Pharmaceutical Market Outlook 2009-2024 shows. Also, pharmaceutical companies will continue to use acquisitions, joint ventures and leveraging of low operational costs in India. That country's main strengths include:

Second-largest population in the world, one predicted to overtake China's by 2035

World's second-fastest-growing economy

Growing middle class with dispensable incomes and expanding healthcare provision

Highly-skilled workforce with competitive manufacturing base.

Therapeutic sales are not the only source of revenues for India's pharmaceutical sector. Increasing costs of research and manufacturing have caused pharmaceutical companies worldwide to outsource operations to lower-cost countries. India's highly competitive pharma industry, with a strong manufacturing base and relatively low overheads, offers strong opportunities for outsourcing both research and production. The growth of India's pharmaceutical business is mostly driven by:Increases in production capacity and efficiencyLegislative reformsThe growth in contract manufacturing opportunities thereIncreases in outsourcing of clinical trials from higher-cost countriesResearch and development capabilities in both small-molecule and biological drugsForeign acquisitions and joint ventures by domestic companies.To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=129531&rt=Indian-Pharmaceutical-Market-Outlook-2009-20241.html OrContact us at :Bharat Book BureauTel: +91 22 27578668Fax: +91 22 27579131Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com Follow us on twitter: http://twitter.com/3bbharatbookby: bharat book bureau

POST COMMENT

Sleep Well For Everyone Focalin For Adhd World Dermatological Market Outlook 2010-2024 Hard Disk Defragmentation: How To Keep Your Hard Drive Healthy How To Cleanse Your Body Safely And Naturally? Mouth Ulcers And Its Remedies Osteoarthritis And Its Remedies Does Acai Berry & Colon Cleanse Essential Combo Work? Global Hepatitis B Vaccines Market Analysis And Forecast Systemic Lupus Erythematosus - Drug Pipeline Analysis Global Multiple Sclerosis - Drug Pipeline Market Prospects Ways To Stop My Acid Reflux Can I Prevent Peach Fuzz After Menopause?